RZV - ETF AI Analysis
Top Page
Invesco S&P Smallcap 600 Pure Value ETF (RZV)
RZV vs. SPDR S&P 500 ETF (SPY)
- AUM
- 279.25M
- Region
- North America
- Expense Ratio
- 0.35%
- Beta
- 0.97
- Issuer
- Invesco
- Inception Date
- Mar 01, 2006
- Dividend Yield
- 1.45%
- Asset Class
- Equity
- Index Tracked
- S&P Small Cap 600 Pure Value
RZV Summary
RZV is the Invesco S&P Smallcap 600 Pure Value ETF, which follows the S&P SmallCap 600 Pure Value Index. It focuses on smaller U.S. companies that appear cheap based on their financials, aiming to find stocks that may be undervalued. The fund spreads money across many sectors, including consumer, industrial, and tech businesses. Well-known names in the fund include Newell Brands and Cracker Barrel. An investor might choose RZV for growth potential and diversification into smaller companies. However, small-cap stocks can be very volatile, so the ETF’s price can move up and down more than the overall market.
How much will it cost me?
The Invesco S&P Smallcap 600 Pure Value ETF (RZV) has an expense ratio of 0.35%, which means you’ll pay $3.50 per year for every $1,000 invested. This is slightly higher than average because it is focused on a niche strategy of actively tracking small-cap value stocks, which requires more management compared to broad, passively managed ETFs.
What would affect this ETF?
The Invesco S&P Smallcap 600 Pure Value ETF (RZV) could benefit from a strong U.S. economy, as small-cap stocks often thrive during periods of economic growth and consumer spending, particularly in sectors like Consumer Cyclical and Financials, which have significant weight in the ETF. However, rising interest rates or economic slowdowns could negatively impact small-cap companies, as they tend to have higher borrowing costs and are more sensitive to market volatility. Additionally, sector-specific challenges, such as fluctuating energy prices or changes in consumer behavior, could influence the performance of top holdings like ViaSat and Par Pacific Holdings.
RZV Top 10 Holdings
RZV is leaning hard into U.S. small-cap value, with a heavy tilt toward consumer-facing names that can swing with the economic mood. MarineMax and Ichor Holdings have been rising this year, giving the fund some much-needed lift, even as Ichor’s recent stretch has been more mixed. On the flip side, Newell Brands and Patterson-UTI are dragging performance, with weaker trends and profitability concerns. Defensive names like Edgewell Personal Care and Acadia Healthcare are steadier, helping balance out the choppier cyclicals in this domestically focused portfolio.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 HZO | Marinemax | 2.10% | $5.82M | $1.16B | 101.66% | 51Neutral |
 ACHC | Acadia Healthcare | 1.95% | $5.40M | $2.79B | 21.18% | 61Neutral |
 CBRL | Cracker Barrel | 1.81% | $5.01M | $1.54B | 71.18% | 55Neutral |
 VSTS | Vestis Corporation | 1.62% | $4.49M | $1.83B | 188.57% | 58Neutral |
 MAN | ManpowerGroup | 1.58% | $4.37M | $1.93B | 16.74% | 54Neutral |
 EPC | Edgewell Personal Care | 1.64% | $4.55M | $1.29B | 39.55% | 58Neutral |
 NWL | Newell Brands | 1.59% | $4.41M | $2.41B | 17.71% | 49Neutral |
 COTY | Coty | 1.55% | $4.29M | $2.82B | -22.89% | 49Neutral |
 VAC | Marriott Vacations Worldwide Corporation | 1.50% | $4.16M | $3.82B | 65.49% | 58Neutral |
 CNXC | Concentrix | 1.49% | $4.13M | $1.70B | -37.89% | 69Neutral |
RZV Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RZV, the sentiment is Negative. The current price of 140.76 is below the 20-day moving average (MA) of 140.99, below the 50-day MA of 145.35, and above the 200-day MA of 137.09, indicating a neutral trend. The MACD of -1.06 indicates Negative momentum. The RSI at 44.13 is Neutral, neither overbought nor oversold. The STOCH value of 51.25 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RZV.
RZV Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| RZV | $140.76 | $148.00(5.14% Upside) | $279.25M | 0.35% | 60Neutral |
 ISCV | $75.89 | $92.37(21.71% Upside) | $667.51M | 0.06% | 66Neutral |
 OSCV | $40.06 | $47.88(19.53% Upside) | $611.23M | 0.79% | 68Neutral |
 XSVM | $66.12 | $78.46(18.66% Upside) | $582.52M | 0.36% | 68Neutral |
 BRSV | $43.30 | $50.42(16.45% Upside) | $301.26M | 0.79% | 70Neutral |
 TCV | $32.20 | $36.94(14.74% Upside) | $201.97M | 0.85% | 63Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| RZV | Invesco S&P Smallcap 600 Pure Value ETF | 140.76 | 24.81 | 21.40% | |
| ISCV | iShares Morningstar Small Cap Value ETF | 75.89 | 10.39 | 15.87% | |
| OSCV | Opus Small Cap Value ETF | 40.06 | 2.79 | 7.48% | |
| XSVM | Invesco S&P SmallCap Value with Momentum ETF | 66.12 | 11.28 | 20.57% | |
| BRSV | EA Bridgeway Select Small-Cap Value ETF | 43.30 | -1.25 | -2.80% | |
| TCV | Towle Value ETF | 32.20 | 6.36 | 24.61% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.